Author:
Faye Sylvain Landry Birane,Lugand Maud Majeres,Offianan André Touré,Dossou-Yovo Aurélie,Kouadio Dieudonné Kouakou M’Bra,Pinto Felix
Abstract
Abstract
Background
Perennial malaria chemoprevention (PMC) aims to protect children at risk from severe malaria by the administration of anti-malarial drugs to children of defined ages throughout the year. Sulfadoxine-pyrimethamine (SP) has been widely used for chemoprevention in Africa and a child-friendly dispersible tablet formulation has recently become available.
Methods
This qualitative non-interventional observational study was conducted in Benin, Côte d’Ivoire, and Mozambique between February and June 2022. Prototype blister packs, dispensing boxes and job aids designed to support dispersible SP deployment for PMC were evaluated using focus group discussions (FGD) and semi-structured in-depth individual interviews (IDI) with health authorities, health personnel, community health workers (CHWs) and caregivers. The aim was to evaluate knowledge and perceptions of malaria and chemoprevention, test understanding of the tools and identify gaps in understanding, satisfaction, user-friendliness and acceptability, and assess the potential role of CHWs in PMC implementation. Interviews were transcribed and imported to ATLAS.ti for encoding and categorization. Thematic content analysis used deductive and inductive coding with cross-referencing of findings between countries and participants to enrich data interpretation. Continuous comparison across the IDI and FGD permitted iterative, collaborative development of materials.
Results
Overall, 106 participants completed IDIs and 70 contributed to FGDs. Malaria was widely recognised as the most common disease affecting children, and PMC was viewed as a positive intervention to support child health. The role of CHWs was perceived differently by the target groups, with caregivers appreciating their trusted status in the community, whereas health authorities preferred clinic-based deployment of PMC by health professionals. Empirical testing of the prototype blister packs, dispensing boxes and job aids highlighted the context-specific expectations of respondents, such as familiar situations and equipment, and identified areas of confusion or low acceptance. A key finding was the need for a clear product identity reflecting malaria.
Conclusion
Simple modifications profoundly affected the perception of PMC and influenced acceptability. Iterative quantitative investigation resulted in PMC-specific materials suited to the local context and socio-cultural norms of the target population with the aim of increasing access to chemoprevention in children most at risk of severe malaria.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Menendez C, Saute F, Greenwood B, Schellenberg D, Snow R, Alonso PL. Avoiding another lost decade in reducing malaria burden in African infants and young children. Lancet Glob Health. 2022;10:e1385–6.
2. WHO. World malaria report. Geneva: World Health Organization. 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022. Accessed 29 Sept 2023.
3. Greenwood B, Schellenberg D. Chemoprevention for the populations of malaria endemic Africa. Diseases. 2022;10:101.
4. WHO. Guidelines for malaria. World Health Organization. 2023. https://www.who.int/publications/i/item/guidelines-for-malaria. Accessed 29 Sept 2023.
5. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, et al. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS ONE. 2008;3: e4000.